ArticleAnnals of biomedical engineering2026
Measurement of 12-Lead ECG Using Multi-Orientation Electrodes on the Left Upper Arm in Healthy Subjects.
Article in Annals of biomedical engineering, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
purposeWearable technologies for cardiac monitoring have facilitated long-term electrocardiogram (ECG) data acquisition. This study presents an alternative approach for obtaining 12-lead associated ECG signals using electrodes strategically placed around the left upper arm (LUA-ECG). We validated whether this LUA-ECG configuration can reliably capture the morphological and quantitative characteristics of standard 12-lead ECG in healthy subjects.
methodThe procedure was conducted in two sequential phases. Initially, standard 12-lead ECG and LUA-ECG were simultaneously recorded from thirty healthy adults. The LUA-ECG system captured 28 differential leads through a multi-electrode configuration strategically positioned around the arm. Among these 28 signals, eight key differential leads corresponding to the standard 12-lead configuration were selected to obtain the 12-lead ECG. In the subsequent phase, the fidelity of the obtained 12-lead ECG was evaluated by comparing it against the standard 12-lead ECG. The comparative analysis focused on key clinical features, including RR interval, PR interval, QRS duration, QT interval, and corrected QT interval (QTc).
resultsThe mean correlation of waveform from eight selected LUA-ECG signals compared with standard 12-lead ECG ranged 0.72 to 0.90. The mean absolute errors (MAE) for RR interval, PR interval, QRS duration, QT interval, and QTc of extracted 12-lead ECG derived from LUA-ECG ranged from 4.57 to 7.77 ms at a 500 Hz sampling rate.
conclusionThe developed LUA-ECG system provides a reliable approach for long-term ECG monitoring. The extracted 12-lead ECG derived from LUA-ECG signal components effectively provides morphological and temporal features associated with conventional 12-lead ECG, demonstrating its potential for extended-duration monitoring applications.
Indexed as
Identifiers
42799948What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.